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ABSTRACT
Antibiotic resistance and its wider implications present us with a growing healthcare crisis. Recent research points to the
environment as an important component for the transmission of resistant bacteria and in the emergence of resistant
pathogens. However, a deeper understanding of the evolutionary and ecological processes that lead to clinical appearance
of resistance genes is still lacking, as is knowledge of environmental dispersal barriers. This calls for better models of how
resistance genes evolve, are mobilized, transferred and disseminated in the environment. Here, we attempt to define the
ecological and evolutionary environmental factors that contribute to resistance development and transmission. Although
mobilization of resistance genes likely occurs continuously, the great majority of such genetic events do not lead to the
establishment of novel resistance factors in bacterial populations, unless there is a selection pressure for maintaining them
or their fitness costs are negligible. To enable preventative measures it is therefore critical to investigate under what
conditions and to what extent environmental selection for resistance takes place. In addition, understanding dispersal
barriers is not only key to evaluate risks, but also to prevent resistant pathogens, as well as novel resistance genes, from
reaching humans.
Keywords: antimicrobial resistance; dissemination; fitness costs; horizontal gene transfer; human health risks; microbial
ecology
INTRODUCTION
Antibiotic resistance accounts for hundreds of thousands of
deaths annually (Review on Antimicrobial Resistance 2014), and
its projected increase has made the WHO recognize it as a ma-
jor global health threat (WHO 2014). Conventionally, the strug-
gle against antibiotic resistance development has mainly taken
place in clinical, community, and in more recent years also
agricultural settings—aiming to reduce transmission and pre-
vent selection of resistant bacteria during antibiotic treatment.
Over the past years, the role of the environment as an impor-
tant source and dissemination route of resistance has been in-
creasingly recognized (Martinez 2008; Wright 2010; Ashbolt et al.
2013; Finley et al. 2013; Pruden et al. 2013; Bengtsson-Palme et al.
2014b; Bondarczuk, Markowicz and Piotrowska-Seget 2015), but
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Figure 1. An overview of the main roles of the external environment in antibi-
otic resistance development and dissemination. Note that none of these pro-
cesses requires a selection pressure for resistance to operate, although such a
selection pressure would facilitate both maintenance and recruitment of resis-
tance genes. Antibiotic exposure may select for resistant bacteria during disper-
sal if those bacteria are able to grow also in the external environment, which is
the case for many opportunistic pathogens. Furthermore, the environment also
serves as a source of opportunistic pathogens that are already resistant, or may
acquire resistance genes from other human-associated bacteria in or on the hu-
man body and then cause resistant infections at a later stage. While both known
and novel resistance genes may be recruited from the environmental resistome,
the most severe long-term health consequences of such acquisitions are likely
when genes not currently present in pathogens are added to their resistance
repertoire.
our understanding of its contribution is still limited. The lack
of knowledge of how, and under which circumstances, the en-
vironment facilitates resistance development makes mitigation
of the emergence and dissemination of mobile resistance fac-
tors problematic (Berendonk et al. 2015). Several authors have
highlighted the need to take on a holistic perspective on an-
tibiotic resistance, including humans, animals and the exter-
nal environment—a so-called one-health approach (Collignon
2013, 2015; So et al. 2015). Increased knowledge of the environ-
mental factors that drive resistance may ultimately allow us to
build models for how resistance emerges and is disseminated
(Hiltunen, Virta and Laine 2017). Although such models would
be descriptive at first, as most of their parameters remain un-
known, and thus lack predictive power, they still would have
value as indicators of the most urgent knowledge gaps to fill in
order to develop mitigation strategies.
This paper aims to conceptualize and define the factors
that influence the emergence, mobilization, dissemination and
maintenance of antibiotic resistance genes in the environment.
We have tried to accommodate both ecological and evolution-
ary aspects, but without any attempt to fully cover the grow-
ing literature on the environmental dimensions of antibiotic re-
sistance (Fig. 1). In order to define those factors, we must first
spell out some basic definitions for which ambiguous meanings
exist in the literature. In this paper, we follow the operational
definition of resistance by Martinez, Coque and Baquero (2015),
which postulates that a strain is resistant against an antibiotic
if its minimal inhibitory concentration (MIC) is higher than for
the corresponding parental wild-type strain. Accordingly, we de-
fine a gene as a ‘resistance gene’ (or ‘resistance factor’) when
its presence allows a bacterium to withstand a higher antibi-
otic concentration or when its absence increases susceptibility
of the antibiotic (Martinez, Baquero and Andersson 2007), a def-
inition that also includes many non-mobile chromosomal resis-
tance genes. We furthermore define ‘novel’ (or ‘new’) resistance
genes as genes that have not previously been described to have
a resistance function, regardless of if they appear in pathogens
or not, and regardless of if they appear on the bacterial
chromosome or on a mobile genetic element. It is complicated
to define ecological emergence (de Haan 2006), and depend-
ing on the viewpoint several definitions of when resistance
genes emerge are possible (Baquero et al. 2015). In this paper,
we will consider the ‘emergence’ of a resistance determinant
as the event where it first appears in a context where it pro-
vides operational resistance. Further, we consider a gene to have
undergone ‘mobilization’ when it appears on a mobile genetic
element, such as a plasmid, transposon or integron. As a conse-
quence of these definitions, most emergence and mobilization
events will in this view remain undetected—at least before they
result in a clinical problem, which many will probably never do.
THE ORIGINS OF RESISTANCE GENES
Novel antibiotic resistance factors could potentially emerge any-
where, at any time. The astounding number of bacterial cells on
Earth, estimated to around 1030—a thousand billion billion bil-
lions (Kallmeyer et al. 2012), provide an immense genetic vari-
ability, and opportunities for mutations, rearrangements and
horizontal gene transfer. Thus, new resistance factors likely ap-
pear regularly, although we never detect the vast majority of
these events. As will be outlined below, there are nevertheless
several reasons to why pathogens are not flooded by novel re-
sistance genes. For a start, resistance factors are generally as-
sociated with some fitness cost. This cost may be particularly
large for genes providing novel resistance functions for a bac-
terium, as their expression may not be sufficiently fine-tuned
and their products may interfere with other cellular functions.
Thus, novel resistance genes will be selected against unless
there is a relatively strong selection pressure to maintain them.
Furthermore, even if such a resistance factor would have a low
or negligible fitness cost, it would still be rare, and may there-
fore not become permanently established in the bacterial pop-
ulation unless there is a positive selection pressure for it (Mar-
tinez 2011). This selection pressure may be weak, but unless it is
present the only way by which a novel resistance factor would
be retained is through genetic drift (Baquero et al. 1998).
MOBILIZATION OF RESISTANCE FACTORS
Similar to the emergence of novel resistance factors, resistance
genes could be mobilized anywhere but need—unless their fit-
ness costs are negligible—a selection pressure to be kept on
a mobile genetic element until they have evolved to present
smaller fitness costs to the host. The subsequent question there-
fore becomes: where are selection pressures strong enough to
promote mobilization of chromosomal resistance genes and
maintenance of already mobile resistance genes? Resistance
factors that have recently been mobilized onto a mobile genetic
element are likely to often be associated with increased fitness
costs, associated with the burden of keeping multiple copies of
the same gene and the difficulty to maintain expression control
of the gene on amobile element. This means that environments
allowing sustained longevity of a resistance gene regardless of
its cost would be of particular importance for the mobilization
of resistance determinants. It is then reasonable to assume that
once a mobile resistance gene has gained a foothold in a bac-
terial community, it can subsequently evolve towards dimin-
ished fitness cost (Salyers and Ama´bile-Cuevas 1997). Resistance
genes with considerably lower fitness costs may of course be re-
cruited to mobile genetic elements, and sub-inhibitory concen-
trations of an antibiotic could then suffice to select for carriage
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of them. It is important to consider that resistance genes have
evolved in a context of competition and interaction between dif-
ferent species, some of which may use antibiotics as warfare
agents. Thus, both known and novel resistance determinants
can be selected for naturally, if they confer a competitive advan-
tage against antibiotics producers, or allow host bacteria to sur-
vive higher concentrations of an antibiotic that they themselves
produce. Such natural selection processes contribute to preserv-
ing an environmental pool of resistance genes, but only indi-
rectly to further establishment of resistance genes in pathogens,
as they are unlikely to drive mobilization of resistance factors.
An oft-neglected aspect of resistance gene mobilization is
that a resistance gene can also be mobilized onto a non-
transferrable mobile genetic element, such as an integron
(Gillings 2017a). The cost-benefit tradeoffs for such mobilization
are poorly investigated, but it can be imagined that on the posi-
tive side for the bacterium, this provides a mechanism for gene
duplication and subsequent neofunctionalization. This may in-
crease the expression levels of a resistance gene or contribute to
fine-tuning of its expression, both of which could be beneficial
under antibiotic selection. On the negative side, transposition of
a gene may result in disruption of other genes or loss of expres-
sion control, both of which could reduce the overall fitness of
the bacterium. The extent to which mobilization into chromo-
somal mobile elements contribute to the development of trans-
ferrable antibiotic resistance is virtually unknown, but it could
potentially be an important step towards resistance recruitment
onto plasmids as integrons often act in tandem with plasmids
and transposons that are transferrable between cells (Stokes and
Gillings 2011). Importantly, while integrons function as effective
gene relocation devices that can capture a wide range of resis-
tance genes, a selection pressure for resistance is still the main
force upholding such relocations in bacterial genomes.
HORIZONTAL TRANSFER OF RESISTANCE
FACTORS
Horizontal gene transfer is central for the spread of novel (and
known) resistance genes, as it allows resistance to expand be-
yond specific clones. This way, gene transfer makes resistance
genes available to a much larger part of the bacterial commu-
nity in a particular environment, often beyond species bound-
aries (Martinez 2011). As for the mobilization of resistance
factors, transfer of genes between bacteria can in theory oc-
cur anywhere. However, for resistance genes to be horizon-
tally transferred from environmental to pathogenic bacteria
they need to, at least temporarily, share the same habitat
(Matte-Tailliez et al. 2002; Wiedenbeck and Cohan 2011). Fur-
thermore, horizontal gene transfer is much more likely to oc-
cur between phylogenetically closely related bacteria (Philip-
pot et al. 2010; Smillie et al. 2011). Finally, transfer of ge-
netic material between bacterial cells is induced by stressors
such as antibiotics (Beaber, Hochhut and Waldor 2004; Hast-
ings, Rosenberg and Slack 2004; Maiques et al. 2006; Jutkina
et al. 2016), and potentially also metals and biocides (Seier-
Petersen et al. 2014; Zhang et al. 2017). Subsequently, antibi-
otic selection also contributes to establishment of transferred
resistance genes in their new host. Thus, resistance transfer
to pathogens could be expected to be relatively frequent be-
tween human-associated bacteria (Salyers, Gupta and Wang
2004; Porse et al. 2017), particularly during treatment with an-
tibiotics. In contrast, transfer of resistance genes to pathogens
from environmental bacteria, which occupy other habitats and
are often less phylogenetically related, would likely be less
common, although environmental stressors may induce hor-
izontal gene transfer to and from (opportunistic) human
pathogens in environmental settings. Thismeans that once a re-
sistance factor has entered a human pathogen, it is more likely
to further spread between commensals and pathogens than
being transferred again into another pathogen from environ-
mental bacteria, and in any case the consequences/contribution
from the latter type of event would be expected to be small
(Bengtsson-Palme and Larsson 2015). Moreover, avoiding trans-
fer of resistance between pathogens (as well as evolutionary
close commensals) is likely impossible, since they share habi-
tats, often are phylogenetically related, and carriage of mobile
resistance factors generally seem to be associated with low fit-
ness costs in pathogens (Salyers and Ama´bile-Cuevas 1997; An-
dersson and Hughes 2010). Somewhat surprisingly, the human
microbiome harbors a fairly large number of resistance genes
that have not (yet) been transferred to human pathogens as far
aswe know (Sommer, Dantas and Church 2009; Sommer, Church
andDantas 2010). The reasons for this are unknown, but one can
speculate that strong barriers to transfer are at play. For exam-
ple,many of the resistance genes in the cultivable bacteria of the
human gut derive from aerobic organisms and are identical to
resistance genes in human pathogens. On the contrary, the un-
cultivable portion of the human microbiome, which mostly cor-
responds to anaerobic organisms, contained much higher frac-
tions of previously undiscovered genes, conferring resistance to
aminoglycosides, amphenicols, beta-lactams and tetracyclines
(Sommer, Dantas and Church 2009). Differences in oxygen pref-
erences may thus be one barrier to resistance transfer, but the
carriers of those genes may also be evolutionary divergent from
most human pathogens, the transfer of their resistance genes
may be complicated by that they have not been mobilized onto
a suitable mobile genetic element, or expression of those genes
in a new host may impose too high fitness costs (Martinez 2011).
The vast majority of existing resistance factors, including
those not yet described, are unlikely to be encountered in
pathogens and human commensals, but would instead be ex-
pected to be present in environmental bacteria (Allen et al. 2010).
Bacteria not typically associated with the human microbiome
may have the opportunity to interact with human-associated
species in various settings. One possibility is that environmental
bacteria can be transiently present in the human microbiome,
after e.g. interaction with wild animals, intake of raw food, or
drinking contaminated water (Allen et al. 2010; De Boeck et al.
2012; Ghaly et al. 2017). The impact of these exposure scenarios
is uncertain as the timeframes for interaction are limited, and
there is virtually no knowledge of the factors triggering trans-
fer of resistance genes in environmental bacteria under this
type of stress. That said, there are also other settings where
human bacteria can interface with animal-associated and en-
vironmental ones. A key consideration in these contexts is the
length of the dispersal route from those milieus back into the
humanpopulation (Baquero, Alvarez-Ortega andMartinez 2009).
A pathogen (or commensal) that acquires a novel resistance fac-
tor from an environmental bacterium, but is eradicated before
it can return to a human host, never causes any clinical resis-
tance problems. Only those that eventually make it back to their
hostsmay become real humanhealth threats. Sewage treatment
plants (STPs) provide an obvious setting that offers interaction
opportunities for a range of different bacterial species, and also
may present sufficient conditions for resistance selection (Rizzo
et al. 2013). Other milieus that could serve as breeding grounds
for resistance transfer can be found in agriculture—particularly
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among livestock (Allen 2014; Bengtsson-Palme 2017), water
bodies (Baquero, Martinez and Canto´n 2008; Lupo, Coyne and
Berendonk 2012), and the food supply chain (Rolain 2013;
Bengtsson-Palme 2017). All these environments have in com-
mon that the exposure routes to humans after a potential
transfer event may be relatively short (see the discussion on dis-
semination below). Finally, transfer of resistance factors from
human pathogens to environmental bacteria is possible, en-
abling human-associated bacteria to use environmental bacte-
rial populations as reservoirs for resistance genes that can later
be re-recruited into the human-associated resistome (Baquero,
Martinez and Canto´n 2008; Martinez 2008). There is evidence for
transfer of resistance genes between diverse organisms such as
Clostridium perfringens, Streptococcus pneumoniae, Enterococcus fae-
calis and strains of Bacteroides (Shoemaker et al. 2001), and hence
such transfer across divergent taxa is not unimaginable. Oppor-
tunistic pathogens usually thriving in soil, such as Burkholde-
ria cepacia, Ochrobactrum intermedium and Stenotrophomonas mal-
tophilia (Berg, Eberl and Hartmann 2005; Johnning et al. 2013),
may be intermediary organisms that can act as recipients of
resistance genes from human-associated bacteria and which
could transfer those genes back at a later point, or even infect
humans themselves. Although this process is not easy to quan-
tify, resistance genes that circulate among pathogens are (as pre-
viously pointed out) nearly impossible to eliminate. Resistance
factors can thus ‘re-emerge’ without being recruited from the
environmental, non-pathogenic, bacteria again. The environ-
ment as a storage or reservoir of resistance genes commonly en-
countered in pathogens is, therefore, in our point of view likely
of lesser concern than the environment as a source for novel re-
sistance factors into pathogens or its role in the dissemination
of resistant pathogens (Fig. 1). Furthermore,measures to prevent
re-recruitment of resistance genes from the environment could
overlap with mitigation strategies to avoid spread of novel re-
sistance factors into pathogens, although which environments
are associated with highest risks will likely differ for the two
scenarios.
DISSEMINATION OF RESISTANT BACTERIA
The main route of exposure for humans to resistant pathogens
is from other people, either in clinics or through the community
setting. Typical dispersal routes here are through body contact
or indirect contact transmission, aerosols, and food prepared by
persons carrying the pathogen (Livermore 2000). These are also
the typical transmission routes for infectious bacteria in general,
and interventions preventing circulation of resistant pathogens
among humans are essentially the same as those applied to pre-
vent the spread of any bacterial pathogen (Rao 1998; Lipsitch,
Bergstrom and Levin 2000; Livermore 2000; Levin, Baquero and
Johnsen 2014). Importantly, proper hygiene routines constitute
the principal dispersal barrier for resistant pathogens, and the
significance of sanitation for preventing the spread of resistant
bacteria between humans cannot be overstated (Mattner et al.
2012).
Apart from transmission between humans, environmen-
tal dissemination routes for resistant bacteria have also been
pointed out as potentially important for the spread of an-
tibiotic resistance (Allen et al. 2010; Finley et al. 2013; Pru-
den et al. 2013; Levin, Baquero and Johnsen 2014; Huijbers
et al. 2015). Again, environments facilitating dissemination
of resistant bacteria also enable spread of non-resistant hu-
man pathogens, and generally also opportunistic pathogens.
Thus, sewage, wastewater treatment plants, water bodies and
travel, but also air-borne aerosols, dust, and food colonized
by bacteria, are important vectors enabling bacterial trans-
mission between hosts through the environment (Fernando,
Collignon and Bell 2010; Molton et al. 2013; Rolain 2013; Pru-
den 2014; Angelin, Evenga˚rd and Palmgren 2015; Barbera´n et al.
2015; Bengtsson-Palme et al. 2015; McEachran et al. 2015; Pal et al.
2016; Bengtsson-Palme 2017). STPs generally discharge their ef-
fluent (which has repeatedly been shown to contain resistance
genes; see e.g. Bengtsson-Palme et al. 2016) into water bodies.
Water contaminated by STP effluents is often used for irrigation
of farmland, for recreational swimming and as drinking water
supply (after further treatment). Domestic animals often drink
such surface water untreated and may subsequently spread re-
sistant bacteria to humans. However, for the dissemination of
resistant bacteria, untreated sewage released into water bodies
poses a considerably larger risk than STP effluents, as STPs often
reduce the relative abundance of the vast majority of resistance
genes, and also lower the total bacterial abundance from ten-
up to thousand-fold (Bengtsson-Palme et al. 2016; Karkman et al.
2016).
Limiting the spread of human-associated bacteria—resistant
or not—requires an understanding of the environmental dis-
persal barriers that exist. Contrary to the case of clinical- and
community-transmitted bacteria, identifying relevant barriers
to dispersal is considerably harder in the environment. We may
here adopt a metacommunity ecology perspective and consider
the human and/or animal hosts of primary pathogens as hab-
itable patches, while most other external environments would
serve as a dispersal matrix (Leibold et al. 2004). Metacommunity
theory suggests that if patches are of equivalent quality in terms
of allowing for a species to thrive and compete, the distance
between patches and the dispersal capability of species deter-
mine their relative success (Bengtsson 2009). Thus, the qual-
ity of the dispersal matrix (i.e. how well it mediates movement
between patches) and the ability to survive between hosts are
fundamental properties for pathogens to spread between hu-
mans through the environment. Some understanding of how
different pathogens survive in the external environment can be
gained from epidemiology, although this is not a particularly
well-studied subject outside of a few select model bacteria. Im-
portantly, the dispersal barriers are largely species specific, as
different bacteria have very different requirements for survival
outside of their preferred habitat. For example, many gut bacte-
ria are, in principle, obligate anaerobes and therefore show poor
survival, and consequently also limited dispersal ability, outside
of the human body. Since survival rather than growth is crit-
ical in the dissemination of human-associated bacteria (resis-
tant or not) through the environment, the advantage of carry-
ing resistance genes in the presence of low concentrations of
antibiotics is likely to be small or negligible for species which
only use the environment as a dispersal matrix. On the other
hand, for those bacteria that utilize the environment as an al-
ternative habitat—or even their main habitat—and therefore
can readily grow there, eventual antibiotic exposure would be
muchmore likely to contribute to the selection of resistance fac-
tors during environmental dissemination. The latter category
includes opportunistic and emerging pathogens, such as Pseu-
domonas putida, Stenotrophomonas maltophilia and Bacillus cereus
(Berg, Eberl and Hartmann 2005). Importantly, this means that
the factors influencing selection for resistant strains during dis-
persal are specific both to the mechanism of the antibiotic and
to the species in question. Another example of species-specific
factors important for these dispersal processes is the ability to
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form inactive dormant stages, such as the highly resilient spores
formed by some pathogenic bacteria, of which Bacillus anthracis
is a good example (Leggett et al. 2012). Dormant life stages could
vastly help bacteria survive in the dispersal matrix, almost re-
gardless of matrix quality, and re-spawn once in a suitable host
(Lennon and Jones 2011; Shade et al. 2012).
The dispersal routes for bacteria through the environment
have not completely evaded investigation, however. Research
on microbial source tracking, usually aiming at identifying the
sources and health risks associated with e.g. leaks of untreated
sewage, have generated some knowledge regarding the persis-
tence and re-infection potential of human gut bacteria in the
environment (Harwood et al. 2014). Furthermore, it is known
that physical forces, such as wind and water movement, can
move bacteria over large distances (Allen et al. 2010). Many bac-
teria have been isolated from air, including species of theMicro-
coccus, Staphylococcus, Bacillus and Aeromonas genera (Go´rny and
Dutkiewicz 2002; Tsai and Macher 2005). Recently, air has also
received attention as an underinvestigated potential route for
dispersal of resistant bacteria (McEachran et al. 2015; Pal et al.
2016; Gat et al. 2017). However, due to the lack of nutrients in
the air environment, the ability to grow in the presence of an-
tibiotics becomes an almost negligible factor compared to sur-
vival and persistence in this dispersal scenario. Thus, air trans-
fer would enable the spread of both resistant and non-resistant
bacteria alike, and although horizontal transfer of resistance be-
tween bacteria in aerosols and on dust particles remain a possi-
bility, such events are less likely to be permanently established
in the recipient genomes unless they are subsequently exposed
to antibiotics in an environment that better permits growth.
Wild birds and animals living close to humans are also
known to harbor bacteria carrying resistance genes, and may
contribute to spreading those genes across large areas (Baquero,
Martinez and Canto´n 2008; Bonnedahl et al. 2009; Stedt et al.
2015). In addition, global food trade has been shown to ship re-
sistant pathogenic bacteria around the world, contributing for
example to the German Shiga-toxin-producing Escherichia coli
(O104:H4) outbreak in 2011 (Buchholz et al. 2011; Rasko et al.
2011). Still, much remains to be understood in terms of disper-
sal limitations, environmental survival, competitiveness versus
environmental species and strains, resistance selection and al-
ternative habitats for human-associated bacteria in the environ-
ment (Hiltunen, Virta and Laine 2017). Even less is known about
how resistance-carrying, non-pathogenic environmental bacte-
ria disperse and interactwith human-associated bacteria. In this
process, opportunistic pathogens with the environment as their
chief habitat may play a very important role in mediating resis-
tance from environmental bacteria to the human microbiome.
The dissemination routes from environments that present a se-
lection pressure for initial emergence, mobilization andmainte-
nance of resistance genes, all theway to humans and/or animals
are poorly understood. These routes need to be delineated, along
with the factors determining survival of environmental bacteria
in various dispersal matrices. This also calls for efforts to moni-
tor the presence of pathogens and resistance genes in a variety
of environmental settings.
EVOLUTIONARY PROCESSES INFLUENCING
ENVIRONMENTAL ANTIBIOTIC RESISTANCE
For the long-term maintenance of antibiotic resistance genes in
bacterial communities, two parallel evolutionary forces are at
play: selection promoting resistance phenotypes, and selection
leading to reduction of the fitness costs associated with carrying
resistance genes (Andersson and Hughes 2010; Baquero, Coque
and de la Cruz 2011; Hernando-Amado et al. 2017). As discussed
earlier, gain and establishment of resistance genes in a bacterial
population are largely dependent on a direct antibiotic selection
pressure (Martinez 2011). The selective forces towards mainte-
nance of resistance genes do not only include direct antibiotic
selection pressure, however. Even in the absence of a direct se-
lection pressure from an antibiotic,mobile resistance genesmay
be favored by co-selection by other substances present, such as
metals and biocides (Baker-Austin et al. 2006; Wales and Davies
2015), as the resistance determinants for some of these com-
pounds can be co-localized to the samemobile genetic elements
as antibiotic resistance genes (Pal et al. 2015). The implications
of co-selection of antibiotic resistance by metals were recently
thoroughly reviewed by Pal et al. (2017). Similarly, exposure to
other stressors than antibiotics may select for increased expres-
sion of genes encoding efflux pumps, which in turn may render
bacteria less susceptible to antibiotics aswell. Although thismay
not immediately contribute to the spread of resistance factors, it
could contribute to the development ofmore efficient resistance
genes by enabling bacteria to withstand low-level antibiotic ex-
posure for longer times, enabling a recently acquired resistance
gene to evolve to bemore efficient and less costlywithin the new
host.
In addition, resistance genes may be maintained because
they confer advantages to the cell even in the absence of a selec-
tion pressure, in essence allowing bacteria to perform intrinsic
functions more efficiently when they carry the resistance gene
(Enne et al. 2004). However, carriage and maintenance of resis-
tance genes usually come with a cost in terms of reduced fit-
ness, although the cost is sometimes small. This cost is (apart
from random reduction by genetic drift) the sole factor that acts
to reduce the frequency of resistance genes in bacterial popula-
tions (Andersson andHughes 2010). Random losses of resistance
genes from bacterial cells happen all the time, but seldom result
in complete elimination of the gene from the community, which
means that once a selection pressure for resistance re-emerges
(such as during antibiotic treatment), resistance development
of bacterial populations previously subjected to resistance se-
lection can be quick (Levin et al. 1997). Selection pressure act-
ing specifically against the carriage of resistance genes is there-
fore crucial for complete eradication of resistance factors from
a community.
The fitness costs associated with carrying and expressing
genes providing antibiotic resistance are largely dictated by the
nature of the resistance mechanism. Bacteria typically become
resistant to antibiotics via (i) upregulation of efflux pumps ex-
porting the substance from the cell, (ii) modifications to the cell
wall or outer membrane, reducing permeability for the antibi-
otic substance, (iii) expression of degradation enzymes that can
render the substance harmless, (iv) protection of the molecular
target of the antibiotic, or (v) alternative means to perform in-
hibited functions (Walsh 2003; Arzanlou, Chai and Venter 2017).
Resistance mechanisms associated with efflux pumps and cell
wall modifications are often caused by mutations in chromo-
somal DNA, although many efflux pumps are transferrable be-
tween bacteria on plasmids. Degradation enzymes, target pro-
tection proteins, and enzymes allowing utilization of alternative
enzymatic pathways are more likely to be transmissible on mo-
bile genetic elements as they add functions to their carrier rather
than modify existing ones. In general, fitness costs associated
with the latter three mechanisms are primarily associated with
the cost of carrying the resistance plasmid and expressing its
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genes, while costs of mutations are related to decreased growth
rate due to changes in essential genes and/or altered resource
usage. In both cases, compensatory mechanisms, including
additional mutations, can reduce fitness costs over time
(Andersson 2003; Hernando-Amado et al. 2017). Under antibiotic
selection, evolution of a bacterial population towards mutation-
mediated resistance depends on both the population size and
themutation rate (Perron et al. 2015). Certainmutations have lit-
tle or no fitness cost, but there seems to be a tendency that those
also confer lower degree of resistance than more costly muta-
tions, at least for some antibiotics (Melnyk, Wong and Kassen
2015). Would the same also be true for resistance genes? The re-
lationships between fitness costs and degree of resistance are
still not elucidated for mobile resistance genes. Recent meta-
analysis of fitness costs associated with different types of resis-
tance factors suggests that while the costs associated with re-
sistance phenotypes vary substantially, the overall trend is that
maintenance of resistance plasmids infers a smaller cost rela-
tive to resistance caused by chromosomal mutations, and the
fitness reduction by carrying a resistance plasmid seems to be
relatively small (Vogwill and MacLean 2015). That said, there are
substantial fitness costs associated with the initial uptake of
horizontally transferred genes (Baltrus 2013), and if resistance
genes are selectively moved from an acquired plasmid to the
chromosome, fitness costs are reduced compared to retaining
the entire source plasmids (Gullberg et al. 2014). Furthermore,
both plasmids and hosts seem to compensate for the initial fit-
ness costs within a comparably small number of generations
through plasmid domestication (Bouma and Lenski 1988; San
Millan et al. 2015; Vogwill and MacLean 2015; Hernando-Amado
et al. 2017). Thus, the majority of horizontally transferred re-
sistance genes may actually present little cost to their hosts.
If that is the case, the advantage of losing a mobile resistance
gene would be small for the individual cell, essentially reduc-
ing the gene loss mechanism to that of stochasticity. Random
losses, however, will often not be sufficient to fully eradicate re-
sistance genes from a population before a selection pressure fa-
voring their presence reemerges (Levin et al. 1997).
Given that most antibiotics in use are derived from natural
compounds produced by microorganisms in the environment,
the presence of genes conferring resistance to those compounds
across a range of habitats is not surprising (Allen et al. 2010;
Pal et al. 2016). Most likely, however, resistance genes did not
evolve as a means to fight the high concentrations of antibiotics
used in therapy, since such high concentrations are unlikely to
be encountered in environments with no or little anthropogenic
impact (Ku¨mmerer 2009a,b). Many antibiotics instead seem to
primarily function as pigments, toxins, and effectors in micro-
bial communities (Demain 1998), or be involved in microbial
signaling (Linares et al. 2006). A curious property of antibiotics
is that, at low concentrations, many of them seem to upregu-
late efflux pumps, escalate mutation rates and mobilize DNA
(Aminov 2009; Bla´zquez et al. 2012). The exact reasons for this
remain poorly understood, but it has been hypothesized that
higher mutation rates enable quicker niche adaption (Aminov
2009). Likewise, it seems reasonable that upregulation of efflux
pumps would also contribute to better adaptability to changing
environments. Thus, a signaling role for antibiotics as secondary
metabolites may be that when resources in the habitat begin to
decay, the release of antibiotics initiates generation of genetic
variability, some of whichmay be favorable in the search for new
suitable niches and habitats. In essence, this would ensuremore
efficient utilization of resources. In this case, resistance genes
may have evolved to balance these needs, or to protect bacteria
against such signaling schemes of other species. This implies
that it might be advantageous to carry resistance genes regard-
less of anthropogenic antibiotic selection. Similarly, resistance
mutations may also have functions aside of providing antibiotic
resistance. For example, the D87G substitution in the target gene
for fluoroquinolones—gyrA—seem to increase tolerance also to
general stress (Webber et al. 2013), whichmay explain why these
substitutions in this position are common among environmen-
tal Escherichia species, also in environments with a low level of
anthropogenic impact (Johnning et al. 2015). The almost ubiq-
uitous presence of resistance genes in a vast range of environ-
ments (Allen et al. 2009; Sommer, Dantas and Church 2009; Lang
et al. 2010; D’Costa et al. 2011; Martiny et al. 2011; Forsberg et al.
2012; Segawa et al. 2012; Munck et al. 2015; Pal et al. 2016) fur-
ther supports that this is the case, and that the cost associated
with carrying resistance genes is almost negligible unless the
niche is extremely resource-poor, with genome streamlining as
a result (Yooseph et al. 2010; Giovannoni, Cameron Thrash and
Temperton 2014; Bengtsson-Palme et al. 2014a).
THE ECOLOGY OF ANTIBIOTIC RESISTANCE
DEVELOPMENT
Based on the above reasoning, we propose that four steps are
central on the route to clinically important antibiotic resistance:
emergence of novel resistance factors, mobilization, transfer
to human pathogens, and dissemination. Notably, these steps
need not to happen in this particular order; transfer to human
pathogens may occur before or after dissemination to the hu-
man microbiome, and certain steps in the process may repeat
(Fig. 2). The arsenal of resistance factors currently present in
pathogens and opportunistic pathogens constitute a set of genes
that are at the later stages of this route. A crucial factor for a re-
sistance gene to reach human pathogens is that it is maintained
throughout all these steps. Resistance genes with high fitness
costs are more likely to be lost in the absence of a selection
pressure, particularly if located on a mobile genetic element.
Furthermore, a scenario with a constant selection pressure by
antibiotics—from the environmental emergence of a resistance
gene to its transfer to a humanpathogen—seems improbable, al-
though one could argue that there are places in the world where
this may be possible. Taken together, it seems reasonable that
successfully maintained resistance genes have either evolved
towards low fitness cost in a mobile context (a sort of evolution-
ary rescue (Gonzalez et al. 2013) on the individual gene level),
or were associated with low fitness costs from the beginning.
Since losses of resistance genes are likely as long as they bestow
their carrier with a significant fitness cost, recently mobilized
genes that do not provide an obvious fitness advantage are un-
doubtedly sorted out early from mobile genetic elements such
as plasmids (Baquero, Tedim and Coque 2013). This highlights
the importance of environments in which resistance genes pro-
vide a strong selective advantage, for example milieus sub-
jected to industrial pollution with antibiotics (Larsson 2014a,b).
Since these environments would also present bacteria with con-
ditions that favor increased mutation frequency, one conse-
quence may be that resistance genes could be present in sev-
eral slightly different variants, all selected for detoxification
efficiency, of which only those with a low fitness cost are main-
tained when the selection pressure is removed (for example,
after dispersal of the carrier to a non-polluted environment).
Given how long the dispersal route from initial mobilization to
human pathogens generally is for a novel resistance gene, it is
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Figure 2. The role of the environment in the recruitment of antibiotic resistance genes (ARGs) to human pathogens includes four major steps: (1) emergence of novel
resistance factors in the environment, (2) mobilization onto mobile genetic elements, (3) transfer of ARGs to human pathogens, and (4) dissemination of ARGs into the
humanmicrobiome. The width of each arrow roughly corresponds to the assumed frequency of each event, although this is of course largely speculative. Many events
are likely more frequent when antibiotic selection pressure is stronger or recurrent. Still, due to the much larger numbers of environmental bacteria than human- and
animal-associated, environmental emergence and mobilization of ARGs is probably common on a global scale. Note that the focus of this figure is on the processes
involving the external environment.
not surprising thatmobile resistance factors found in pathogens
today are terribly hard to eliminate from bacterial populations
(Levin et al. 1997; Andersson 2003; Jernberg et al. 2007; Lo¨fmark
et al. 2008) and seem to present little fitness cost to their carri-
ers (Enne et al. 2004; Andersson and Hughes 2010; Gullberg et al.
2014; Vogwill andMacLean 2015). This suggests that once a resis-
tance gene is widely spread among human pathogens (or even
among human commensals), part of the game is lost and we
are restricted to manage its spread. Mitigation of the spread of
resistance factors to human pathogens should therefore ideally
take place before they get a foothold in the human microbiome.
Thus, detection of resistance determinants in the environment
that are not yet widespread among clinical bacteria should be
an important component in risk assessment and management
of antibiotic resistance (Bengtsson-Palme and Larsson 2015).
WHICH ENVIRONMENTS POSE THE MOST
PERTINENT RISKS TO HUMAN HEALTH?
Ultimately, the most urgent reason to study antibiotic resis-
tance in the environment is to gain further insights into health
risks for humans and domestic animals that often are depen-
dent on effective antibiotics. This knowledge can then ide-
ally be used to design interventions that could prevent or de-
lay the recruitment of resistance factors to pathogens from
environmental bacteria and reduce environmental dissemina-
tion of resistant pathogens. To identify suitable mitigation
strategies, we first need to define what environments and sce-
narios constitute the most severe risks. This, however, is not
completely straightforward. Some have argued that themost se-
vere risk scenarios involve known resistance genes that have
previously been reported to reside on mobile genetic elements
hosted by human bacterial pathogens (Martinez, Coque and Ba-
quero 2015). This is a valid argument when such genes are en-
countered in the human microbiome, but while they are clearly
of importance, finding them in environmental bacterial com-
munities is not necessarily indicative of a high-risk situation.
Well-known resistance genes present on mobile genetic ele-
ments easily spread with human feces, and detection of them
in the external environment may be an indication of human fe-
cal contamination (Pruden et al. 2006; Pruden, Arabi and Stor-
teboom 2012; Bengtsson-Palme, Larsson and Kristiansson 2017).
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Table 1. Human health risks associated with environmental antibiotic resistance and examples of risk environments and appropriate
mitigations.
Risk scenario Environments of particular concern Possible mitigations
Emergence and fixation of
novel resistance genes
Human and animal microbiome Reduce and optimize antibiotics usage
Intensive aquaculture Restrict antibiotics usage
Environments polluted by discharges from
antibiotic manufacturing
Incentivize better control of discharges
Mobilization and transfer of
resistance genes to human
pathogens
Environments polluted by discharges from
antibiotic manufacturing
Incentivize better control of discharges
Sewage Disinfection of treated sewage and sludge
Human and animal microbiome Reduce antibiotics usage, limit transmission of pathogens
Dissemination of resistant
bacteria
Human-to-human contacts, hospitals Hygiene
Contact with environmental opportunistic
pathogens, directly or through food
Hygiene, proper handling of fresh produce
Animal husbandry Reduce antibiotics usage, create transmission barriers
between animals, humans and the external environment
Poorly treated sewage Improved infrastructure for sewage treatment
Risks associated with human fecal pollution should not be ne-
glected, but are primarily related to the dissemination of already
resistant bacteria. Furthermore, these genes are already circu-
lating among pathogens and, as argued earlier, transfer of them
between pathogens within the human microbiome is expected
to be vastly more frequent than transfer of the same genes from
environmental bacteria. Thus, in terms of future treatment out-
comes, the clinical consequences of recruitment of resistance
genes already present among pathogens from environmental
sources are likely to be minor (Bengtsson-Palme and Larsson
2015).
The risk landscape can essentially be partitioned into three
main components: (i) the risks for mobilization and subse-
quently permanent establishment of (novel) resistance deter-
minants, (ii) the risks for recruitment of resistance genes not
carried by human pathogens through horizontal gene trans-
fer, and (iii) the risks associated with dissemination of resis-
tant bacteria (pathogens or not) through the environment to
the human population (Table 1). Antibiotic selection may in-
fluence all these components, particularly in the former two
cases, while dispersal barriers are most critical for the latter one
(Fig. 2). That said, selection could play a major role in the dis-
semination of resistant bacteria which have the environment
as their primary habitat, including opportunistic pathogens.
Although mobilization of resistance genes could happen any-
where, stronger selection pressures are directly related to higher
risks for their persistent establishment in bacterial populations,
as the fitness costs for carrying recently emerged mobile resis-
tance determinants probably are high. Recently mobilized re-
sistance genes that do not confer a fitness advantage are likely
to quickly be selected against and lost in microbial communi-
ties. This identifies environments in which antibiotics concen-
trations are clearly above establishedminimal selective concen-
trations (MSCs), or even the MICs for many bacteria, as partic-
ular high-risk environments in early resistance emergence and
mobilization. This includes the human and animal microbiome
during antibiotics treatment, intensive aquaculture assisted by
antibiotics (Cabello 2006), as well as environments polluted
with high levels of antibiotics from industrial sources (Larsson
2014b). The conditions bacteria face within treatment plants
treating wastewater from antibiotics production are largely un-
explored, but are also likely to be extensively selective, result-
ing in very limited diversity of bacteria present in such set-
tings (Marathe et al. 2016). Furthermore, as sub-lethal concen-
trations of antibiotics also can select for resistance (Gullberg
et al. 2011, 2014; Lundstro¨m et al. 2016), attention has to be paid
to raw sewage, agricultural settings and STPs, where concen-
trations of antibiotics around the predicted MSCs have been
determined (Michael et al. 2013; Bengtsson-Palme and Larsson
2016a). Furthermore,mobilization and transfer of resistance fac-
tors also increase during antibiotics exposure (Beaber, Hochhut
andWaldor 2004; Hocquet et al. 2012), and similarly occur even at
sub-inhibitory antibiotics concentrations (Do¨rr, Lewis and Vulic´
2009; Jutkina et al. 2016, 2017). Thus, polluted environments once
again pose a high risk, but sewage, for example, may also con-
tain sufficient toxicant concentrations to induce horizontal gene
transfer.
For the transfer of resistance to human pathogens, the abun-
dance of pathogenic bacteria that can act as recipients is crucial.
This means that the human microbiome could potentially play
a role in this process, and that human commensals may act as
intermediary resistance reservoirs (Sommer, Church andDantas
2010; Forslund et al. 2013). The role of human commensals in the
transfer of resistance from environmental bacteria to pathogens
is however not well investigated. Furthermore, transient en-
vironmental bacteria could potentially carry resistance genes
into the human microbiome, where these genes could be trans-
ferred to human-associated bacteria, including (opportunistic)
pathogens. However, for most transient bacteria, the interaction
times with human-associated bacteria are likely to be short. In
addition, animals may also serve as intermediate hosts for re-
sistant bacteria, and contribute a breeding ground for resistance
transfer to human pathogens (Allen et al. 2010). Risks associated
with transfer of novel resistance genes to human pathogens in
STPs appear somewhat smaller due to seemingly lacking selec-
tion pressures and lower proportions of human-associated bac-
teria in the effluent (Bengtsson-Palme et al. 2016), although such
transfer is certainly not impossible. The dissemination routes
for environmental bacteria carrying resistance genes are much
less clear. Regardless, the most critical factor is whether there
is a quick dispersal route to the human population (Baquero,
Alvarez-Ortega and Martinez 2009). The shorter the ‘length’ of
this route, the higher the risks associated with a particular
environment.
Taken together, it is not clear how high-risk settings
for human health associated with environmental antibiotic
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resistance should be defined. However, obvious scenarios where
interventions could already be applied are environments with
strong selection pressures from antibiotics (Table 1). Thus, lim-
iting discharges of pharmaceutical waste from antibiotics pro-
duction and reducing unnecessary use of antibiotics in humans,
animals, and aquaculture are all important first steps towards
mitigation of environmental antibiotic resistance development
(Pruden et al. 2013; Bengtsson-Palme and Larsson 2016a,b; Re-
view on Antimicrobial Resistance 2016). Second, identifying and
reducing dispersal routes for resistant bacteria to the humanmi-
crobiome should also be a high priority. For dissemination, tar-
geting critical control points for resistance spread, such as STPs,
would be of particular importance (Berendonk et al. 2015). For
example, disinfection of treated effluent could be an efficient
means of controlling the dispersal of resistant bacteria. How-
ever, building out any kind ofmodern treatment of sewage in de-
veloping countries would probably have larger effects on resis-
tance dissemination andwould thus be a strategy of even higher
priority (Pruden et al. 2013; Graham et al. 2014; Kookana et al.
2014), as the resistance problem is global (Johnson and Wood-
ford 2013; Molton et al. 2013; Bengtsson-Palme et al. 2015).
A FUTURE OF RESISTANT ‘SUPERBUGS’?
Apart from the obvious health hazards associated with
increased prevalence of resistance genes among human
pathogens, there are additional disturbing circumstances sug-
gesting that the future holds a yet darker development than
what we may currently appreciate. First of all, many resistance
genes seem to be associated with small fitness costs for their
hosts, and are readily transferred both between bacteria and be-
tween plasmids (Normark and Normark 2002). Resistance genes
with low costs tend to bemaintained, and can evolve in response
to more efficient variants of the same antibiotic, as observed
for cephalosporins and the TEM beta-lactamases (Baquero et al.
1998) as well as tigecycline and some tet tetracycline resistance
genes (Linkevicius, Sandegren and Andersson 2016). Further-
more, resistance genes against several different antibiotics can
accumulate on the samemobile genetic element. Given that sev-
eral broad-spectrumantibiotic classes are used to treat the same
bacterial strains, such co-localization is more likely than not to
emerge over time. Once two genes have been co-localized on the
same plasmid in this way, the evolutionary forces to separate
them are generally small relative to the gain of keeping them on
the plasmid in the face of eventual antibiotic exposure. Thus, we
would expect to see an increase of bacteria with plasmid-borne
multiresistance phenotypes, and that the rate of this increase
would also increase with time. Indeed, this is what has been ob-
served among clinical isolates (Livermore 2009; European Cen-
tre for Disease Prevention and Control 2013). Importantly, this
increase would appear even if antibiotics usage did not surge.
Troublingly, global antibiotics usage is also on the rise (Laxmi-
narayan 2014), likely accelerating the multiresistance problem
even further. The use of biocides and metals as antibacterials
may also promotemultidrug resistance, although towhat extent
is still uncertain (Baker-Austin et al. 2006; Pal et al. 2015; Wales
and Davies 2015; Pal et al. 2017).
Multidrug resistance may not be the only problem we will
face in the future though. Bacteria can generate genetic di-
versity through mutations, recombination and horizontal gene
transfer. Each of these processes is under balancing selection,
where the benefits of generating potentially adaptive genetic
variants areweighted against the risk for fitness-reducingmuta-
tions (Gillings 2013). Antibiotic exposure has been shown to in-
crease the mutation and recombination frequencies in bacteria,
even at sub-inhibitory levels, through the SOS response (Beaber,
Hochhut andWaldor 2004; Lo´pez et al. 2007; Bla´zquez et al. 2012).
Exposure of environmental bacteria to varying levels of antibi-
otics is therefore likely to generate variants with higher rates
of genetic change, in addition to the selecting for resistance.
Since populations of bacteria that have higher mutation rates
are more likely to rapidly acquire beneficial mutations, and also
more likely to quickly generate compensatory genetic changes,
antibiotic exposure may select for fixation of bacterial popu-
lations with generally higher rates of genetic change (Gillings
and Stokes 2012). In addition, antibiotics are often released into
the environment together with bacteria carrying integrons and
other mobile genetic elements (Gaze et al. 2011, 2013). Since
integrase activity is also induced by antibiotics (Maiques et al.
2006), this may further increase bacterial evolvability, generat-
ing ever more complex mobile genetic elements (Gillings 2014,
2017b). If such reorganizations of resistance genes come to-
gether with a generally increased mutation rate, the net result
would be an even quicker evolution towards mobile resistance
genes with lower fitness costs. It is impossible to predict exactly
what consequences this may have for bacterial pangenomes.
Since integrons and other mobile genetic elements allow bac-
teria to adapt faster to new niches (Gillings 2014), genes mo-
bilized in the future would likely not be restricted to confer-
ring antibiotic resistance, but may also encompass genes that
provide a fitness advantage in terms of adaption to changing
environments. Thus, genes allowing bacteria to survive highly
variable abiotic conditions, handle toxicants, utilize novel car-
bon sources, compete with other microbes, adhere to different
types of surfaces, re-engineer their ecosystems, and allow for-
mation of highly durable spores would be good candidates for
future mobilization. From a human health perspective, it is easy
to imagine that selection by antibiotics would favor strains with
attributes that are beneficial for colonization and invasion of the
human host. This could include mobilization of genes involved
in virulence, transmission and pathogenicity (Gillings 2014), but
also genes that increase competitive ability with human com-
mensals. This paints a picture of a bleak future in which human
pathogens would not only be non-treatable by most antibiotics,
but also would become more aggressive and spread more easily
between humans. Wemight already be witnessing a foretaste of
what is to come, with hypervirulent Klebsiella pneumoniae resis-
tant to all antibiotics tested recently appearing in Chinese hos-
pitals (Gu et al. 2017). It is thus important to understand not only
the risks for resistance transmission, but also the evolutionary
consequences of antibiotic releases into the environment.
CONCLUDING REMARKS
In this paper, we have attempted to define and formalize rel-
evant ecological and environmental factors for antibiotic re-
sistance development and transmission. We propose that al-
though emergence of novel resistance factors and mobiliza-
tion of existing ones probably happen continuously, only few
of these determinants are selected for and permanently estab-
lished among bacterial populations. As a consequence, those
that do make it to pathogenic species are likely to be evolved
towards conveying very little fitness cost to their hosts, and
will thus be hard to eliminate from pathogen populations.
Successful mitigation strategies for environmental resistance
development are therefore in principle limited to (i) avoiding
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creation of settings that select for, mobilize and allow persis-
tence of resistance genes in bacterial communities, (ii) reduc-
ing dispersal routes for resistant bacteria to the human mi-
crobiome, and (iii) limiting the selection pressure for resistant
pathogens (i.e. prudent use of antibiotics for humans and ani-
mals). The diversity of resistance genes present in the environ-
ment suggests that there are still many more resistance genes
available for pathogens to recruit. Resistance genes common
among the bacterial populations in the human microbiome are
not likely to be eradicated, even in the absence of antibiotics se-
lection. Thus, the mobile resistance genes that are already cir-
culating among human pathogens may easily re-emerge dur-
ing antibiotics treatment. Recruitment of additional novel resis-
tance genes into pathogens, on the other hand, has the potential
to cause devastating consequences for human health, as mobile
resistance genes against new antibiotics, or more efficient resis-
tancemechanisms against the ones that already face resistance,
would further reduce treatment options.
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